Neurofilament Light Chain as a Potential Biomarker in Plasma for Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review and a Meta-Analysis

Neurofilament Light Chain as a Potential Biomarker in Plasma for Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review and a Meta-Analysis

Background: Plasma neurofilament light (NfL) is an intermediate filamentous protein involved in stabilizing axonal structure and promoting axon growth. Recent clinical studies have reported increased NfL levels in the plasma of Alzheimer’s disease (AD) patients and patients with mild cognitive impai...

Full description

Bibliographic Details
Main Authors:	Zhenyi Fan, Xiaoxia Liu, Jie Liu, Caijing Chen, Min Zhou
Format:	Article
Language:	English
Published:	IMR Press 2023-06-01
Series:	Journal of Integrative Neuroscience
Subjects:	alzheimer's disease mild cognitive impairment neurofilament light chain meta-analysis
Online Access:	https://www.imrpress.com/journal/JIN/22/4/10.31083/j.jin2204085

Similar Items

Serum neurofilament light chain and inflammatory cytokines as biomarkers for early detection of mild cognitive impairment
by: Xinyang Jing, et al.
Published: (2024-04-01)

Plasma biomarkers for diagnosis of Alzheimer's disease and prediction of cognitive decline in individuals with mild cognitive impairment
by: Pia Kivisäkk, et al.
Published: (2023-03-01)

Evaluation of Neurofilament Light Chain as a Biomarker of Neurodegeneration in X-Linked Childhood Cerebral Adrenoleukodystrophy
by: Hongge Wang, et al.
Published: (2022-03-01)

Plasma neurofilament light chain in memory clinic practice: Evidence from a real-life study
by: Karl Götze, et al.
Published: (2023-01-01)

Association Between Serum Neurofilament Light Chain and Cognitive Performance Among Older Adults in the United States: A Cross-Sectional Study
by: Yuanyuan Gao, et al.
Published: (2023-10-01)

Blood Neurofilament Levels Predict Cognitive Decline across the Alzheimer’s Disease Continuum
by: Sylvain Lehmann, et al.
Published: (2023-12-01)

Serum phosphorylated tau protein 181 and neurofilament light chain in cognitively impaired heart failure patients
by: Jan Traub, et al.
Published: (2022-10-01)

Neurofilaments Light Chain in Neurodegenerative Dementias: A Review of Imaging Correlates
by: Chiara Gallingani, et al.
Published: (2024-03-01)

Aerobic exercise does not affect serum neurofilament light in patients with mild Alzheimer’s disease
by: Kristian Steen Frederiksen, et al.
Published: (2023-01-01)

Review of Neurofilaments as Biomarkers in Sepsis-Associated Encephalopathy
by: Zhang Q, et al.
Published: (2023-01-01)

Blood Neurofilament Light Chain: The Neurologist’s Troponin?
by: Simon Thebault, et al.
Published: (2020-11-01)

Plasma Concentrations of Neurofilament Light Chain Protein and Brain-Derived Neurotrophic Factor as Consistent Biomarkers of Cognitive Impairment in Alcohol Use Disorder
by: Nerea Requena-Ocaña, et al.
Published: (2023-01-01)

Neurofilament Light Chain in Aqueous Humor as a Marker of Neurodegeneration in Glaucoma
by: Lin JB, et al.
Published: (2023-08-01)

Serum neurofilament light chain level as a predictor of cognitive stage transition
by: Eun-Hye Lee, et al.
Published: (2022-01-01)

Annual Plasma Neurofilament Dynamics Is a Sensitive Biomarker of Disease Activity in Patients with Multiple Sclerosis
by: Miriam Fedičová, et al.
Published: (2023-04-01)

Serum neurofilament light chain in COVID-19 and the influence of renal function
by: Peter Körtvelyessy, et al.
Published: (2023-09-01)

Plasma Neurofilament Light Chains as Blood-Based Biomarkers for Early Diagnosis of Canine Cognitive Dysfunction Syndrome
by: Chung-Hsin Wu, et al.
Published: (2023-09-01)

Blood and CSF chemokines in Alzheimer’s disease and mild cognitive impairment: a systematic review and meta-analysis
by: Futao Zhou, et al.
Published: (2023-06-01)

Optimizing detection of Alzheimer’s disease in mild cognitive impairment: a 4-year biomarker study of mild behavioral impairment in ADNI and MEMENTO
by: Zahinoor Ismail, et al.
Published: (2023-07-01)

Cluster analysis dissecting cognitive deficits in older adults with major depressive disorder and the association with neurofilament light chain
by: Cynthia Yi-an Chen, et al.
Published: (2024-04-01)

SIMOA-based analysis of plasma NFL levels in MCI and AD patients: a systematic review and meta-analysis
by: Hadi Sahrai, et al.
Published: (2023-09-01)

Association of cognitive function with Neurofilament light chain in the aqueous humor of human eye
by: Jianhao Bai, et al.
Published: (2022-11-01)

Probiotics for Mild Cognitive Impairment and Alzheimer’s Disease: A Systematic Review and Meta-Analysis
by: Guangsu Zhu, et al.
Published: (2021-07-01)

Serum Neurofilament Light Chain in Patients With Atrial Fibrillation
by: Karl Sjölin, et al.
Published: (2022-07-01)

Guidance for use of neurofilament light chain as a cerebrospinal fluid and blood biomarker in multiple sclerosis management
by: Mark S. Freedman, et al.
Published: (2024-03-01)

Evidence of polygenic regulation of the physiological presence of neurofilament light chain in human serum
by: Marisol Herrera-Rivero, et al.
Published: (2023-03-01)

The diagnostic significance of neurofilament heavy chains in cerebrospinal fluid in amyotrophic lateral sclerosis
by: Anastasia V. Vladykina, et al.
Published: (2021-03-01)

Brain atrophy and white matter hyperintensities are independently associated with plasma neurofilament light chain in an Asian cohort of cognitively impaired patients with concomitant cerebral small vessel disease
by: Joyce R. Chong, et al.
Published: (2023-01-01)

Alzheimer’s Disease, Mild Cognitive Impairment and Mediterranean Diet. A Systematic Review and Dose-Response Meta-Analysis
by: Natalia García-Casares, et al.
Published: (2021-10-01)

Value of Neurofilament Light Chain as a Biomarker in Peripheral Neuropathy
by: SUN Xiaoling, HUANG Kaiwei, WAN Xinbei, WU Ying, LI Zhijun
Published: (2022-11-01)

Non-invasive biomarkers for mild cognitive impairment and Alzheimer's disease
by: Marina Botello-Marabotto, et al.
Published: (2023-10-01)

Serum Neurofilament and Free Light Chain Levels in Patients Undergoing Treatment for Chronic Inflammatory Demyelinating Polyneuropathy
by: Marco Luigetti, et al.
Published: (2024-01-01)

Elevated Neurofilament Light Chain in Cerebrospinal Fluid and Plasma Reflect Inflammatory MRI Activity in Neurosarcoidosis
by: Keld-Erik Byg, et al.
Published: (2021-02-01)

Neurofilaments in spinocerebellar ataxia type 3: blood biomarkers at the preataxic and ataxic stage in humans and mice
by: Carlo Wilke, et al.
Published: (2020-07-01)

Neurofilament light chain levels in serum among a large mixed memory clinic cohort: Confounders and diagnostic usefulness
by: Anja Hviid Simonsen, et al.
Published: (2023-10-01)

Serum neurofilament light levels are predictive of all-cause mortality in late middle-aged individuals
by: Andrew D. Nguyen, et al.
Published: (2022-08-01)

Neurofilament light chain in plasma as a sensitive diagnostic biomarker of peripheral neurotoxicity: In Vivo mouse studies with oxaliplatin and paclitaxel - NeuroDeRisk project
by: David Balayssac, et al.
Published: (2023-11-01)

Mild behavioral impairment in early Alzheimer’s disease and its association with APOE and BDNF risk genetic polymorphisms
by: Veronika Matuskova, et al.
Published: (2024-01-01)

Serum neurofilament light chain levels in patients with cognitive deficits and movement disorders: comparison of cerebrospinal and serum neurofilament light chain levels with other biomarkers
by: Richard Novobilský, et al.
Published: (2023-12-01)

Studies to Assess the Utility of Serum Neurofilament Light Chain as a Biomarker in Chemotherapy-Induced Peripheral Neuropathy
by: Guido Cavaletti, et al.
Published: (2023-08-01)